COO

+ Watchlist + Portfolio

The Cooper Companies, Inc.

Regulated industry Physical productsTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $57.41
52-Week Range: $51.01 – $89.83
Market Cap: $10.82B
P/E (TTM): 19.56
EPS (TTM): 2.91
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.30
PEG Ratio: 0.54
Return on Equity: 6.84%
Return on Assets: 2.73%
Gross Margin: 65.93%
Operating Margin: 20.82%
Profit Margin: 13.46%
Current Ratio: 1.22
Debt/Equity: 0.34
Total Debt: $2.80B
Free Cash Flow: $542.65M
Revenue Growth: 0.60%
Earnings Growth: 357.10%
Enterprise Value: $13.47B

COO Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$3.31B	$3.59B	$3.90B	$4.09B
Cost of Revenue	$1.17B	$1.24B	$1.30B	$1.41B
Gross Profit	$2.14B	$2.36B	$2.60B	$2.68B
Research & Development	$110.30M	$137.40M	$155.10M	$172.20M
Selling, General & Admin	$1.34B	$1.50B	$1.53B	$1.63B
Operating Expenses	$1.63B	$1.82B	$1.89B	$2.00B
Operating Income	$507.60M	$533.10M	$705.70M	$682.90M
EBITDA	$878.70M	$885.90M	$1.07B	$1.04B
Pretax Income	$475.30M	$412.90M	$582.30M	$566.50M
Income Tax	$89.50M	$118.70M	$190.00M	$191.60M
Net Income	$385.80M	$294.20M	$392.30M	$374.90M
Diluted EPS	1.94	1.48	1.96	1.87
Diluted Shares	198.80M	199.20M	200.40M	200.00M

COO Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$138.20M	$120.80M	$107.60M	$110.60M
Receivables	$557.80M	$609.70M	$717.00M	$829.00M
Inventory	$628.70M	$735.60M	$802.70M	$846.00M
Current Assets	$1.53B	$1.70B	$1.95B	$2.11B
Total Assets	$11.49B	$11.66B	$12.32B	$12.39B
Current Liabilities	$1.28B	$969.00M	$1.02B	$1.11B
Long-Term Debt	$2.35B	$2.52B	$2.55B	$2.46B
Total Debt	$2.76B	$2.57B	$2.58B	$2.51B
Total Liabilities	$4.32B	$4.11B	$4.23B	$4.16B
Retained Earnings	$6.58B	$6.88B	$7.27B	$7.64B
Shareholders' Equity	$7.17B	$7.55B	$8.08B	$8.24B
Working Capital	$253.40M	$735.90M	$928.70M	$993.60M
Net Debt	$2.60B	$2.44B	$2.47B	$2.39B

COO Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$692.40M	$607.50M	$709.30M	$796.10M
Capital Expenditure	-$242.00M	-$392.50M	-$421.20M	-$362.40M
Free Cash Flow	$450.40M	$215.00M	$288.10M	$433.70M
Depreciation & Amortisation	$346.10M	$367.70M	$375.10M	$377.40M
Stock-Based Compensation	$54.20M	$62.10M	$75.10M	$70.50M
Investing Cash Flow	-$1.83B	-$449.00M	-$764.60M	-$372.90M
Financing Cash Flow	$1.19B	-$173.90M	$39.20M	-$425.90M
Dividends Paid	-$3.00M	-$3.00M	$0.00	$0.00
Share Repurchases	-$78.50M	$0.00	$0.00	-$290.10M
Net Change in Cash	$54.90M	-$15.40M	-$16.10M	-$2.70M

COO Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Revenue	$1.00B	$1.06B	$1.07B	$1.02B	$1.08B	$1.07B
Cost of Revenue	$323.20M	$368.30M	$414.30M	$328.90M	$346.10M	$354.30M
Gross Profit	$679.10M	$692.00M	$650.80M	$695.20M	$735.40M	$711.90M
Research & Development	$45.50M	$44.60M	$41.40M	$44.30M	$42.50M	$41.60M
Selling, General & Admin	$399.00M	$421.70M	$419.20M	$390.20M	$676.20M	$401.30M
Operating Expenses	$494.30M	$516.30M	$510.40M	$482.40M	$766.40M	$489.90M
Operating Income	$184.80M	$175.70M	$140.40M	$212.80M	-$31.00M	$222.00M
EBITDA	$261.30M	$272.70M	$239.60M	$310.10M	$67.90M	$318.00M
Pretax Income	$144.50M	$151.90M	$116.80M	$192.20M	-$48.40M	$201.80M
Income Tax	$56.80M	$53.60M	$32.20M	$61.40M	$29.50M	-$231.00M
Net Income	$87.70M	$98.30M	$84.60M	$130.80M	-$77.90M	$432.80M
Diluted EPS	0.44	0.49	0.43	0.66	-0.40	2.24
Diluted Shares	200.70M	200.00M	198.10M	196.70M	195.00M	193.40M

COO Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Cash & Equivalents	$116.20M	$124.90M	$110.60M	$124.90M	$138.80M	$154.70M
Receivables	$780.90M	$792.30M	$829.00M	$807.10M	$809.20M	$788.90M
Inventory	$880.30M	$881.00M	$846.00M	$876.40M	$896.40M	$911.50M
Current Assets	$2.13B	$2.14B	$2.11B	$2.13B	$2.30B	$2.28B
Total Assets	$12.41B	$12.38B	$12.39B	$12.42B	$12.48B	$12.67B
Current Liabilities	$1.01B	$1.01B	$1.11B	$1.60B	$1.80B	$1.87B
Long-Term Debt	$2.52B	$2.43B	$2.46B	$1.88B	$1.86B	$1.91B
Total Debt	$2.59B	$2.48B	$2.51B	$2.50B	$2.46B	$2.54B
Total Liabilities	$4.13B	$4.02B	$4.16B	$4.06B	$4.24B	$4.34B
Retained Earnings	$7.46B	$7.56B	$7.64B	$7.77B	$7.70B	$8.13B
Shareholders' Equity	$8.29B	$8.35B	$8.24B	$8.36B	$8.24B	$8.33B
Working Capital	$1.11B	$1.13B	$993.60M	$538.10M	$495.10M	$414.90M
Net Debt	$2.47B	$2.35B	$2.39B	$2.37B	$2.32B	$2.39B

COO Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Operating Cash Flow	$96.20M	$261.40M	$247.90M	$260.90M	$182.80M	$341.70M
Capital Expenditure	-$78.10M	-$96.90M	-$98.00M	-$102.20M	-$86.40M	-$68.70M
Free Cash Flow	$18.10M	$164.50M	$149.90M	$158.70M	$96.40M	$273.00M
Depreciation & Amortisation	$92.60M	$95.40M	$98.40M	$95.50M	$95.40M	$94.70M
Investing Cash Flow	-$79.20M	-$98.10M	-$98.80M	-$102.90M	-$90.00M	-$69.80M
Financing Cash Flow	-$8.60M	-$156.30M	-$164.40M	-$147.90M	-$75.80M	-$252.90M
Share Repurchases	-$40.60M	-$52.70M	-$196.80M	-$92.50M	-$15.50M	-$339.20M
Net Change in Cash	$8.40M	$7.00M	-$15.30M	$10.10M	$17.00M	$19.00M

Market Snapshot

About

The Cooper Companies, Inc. is a global medical device company headquartered in San Ramon, California, operating through two business units: CooperVision and CooperSurgical. CooperVision develops and manufactures soft contact lenses for vision correction, including daily disposable, monthly, and specialty lenses for conditions like myopia management and astigmatism. CooperSurgical provides medical devices, fertility solutions, and genomic services for women's healthcare. The company serves customers in over 100 countries and is a leading provider in both the contact lens and women's health markets.